Core Viewpoint - BriaCell Therapeutics Corp. has successfully closed a public offering of 5,366,726 units, raising approximately US$30 million to support its business objectives and working capital needs [1][2]. Group 1: Offering Details - Each unit in the offering consists of one common share (or one pre-funded warrant) and one warrant, sold at a price of US$5.59 per unit [1]. - The warrants are immediately exercisable at an exercise price of US$6.93 per share and will expire five years from the date of issuance [1]. - The warrants have been approved for listing on the Nasdaq Capital Market under the symbol "BCTXL" and began trading on January 14, 2026 [1]. Group 2: Use of Proceeds - The net proceeds from the offering will be utilized for working capital requirements, general corporate purposes, and advancing the company's business objectives [2]. Group 3: Regulatory Information - A registration statement related to the securities was filed with the SEC on December 23, 2025, and became effective on January 13, 2026 [3]. - The offering was conducted in accordance with the exemption set forth in Section 602.1 of the TSX Company Manual [2]. Group 4: Company Overview - BriaCell is a clinical-stage biotechnology company focused on developing novel immunotherapies aimed at transforming cancer care [5].

Market Overview - U.S. stocks experienced a decline, with the Nasdaq Composite falling over 350 points, the Dow down 0.55% to 48,922.97, the NASDAQ down 1.58% to 23,335.70, and the S&P 500 down 1.06% to 6,889.76 [1] - Energy shares increased by 2%, while information technology stocks dipped by 1.3% [1] Retail Sales and Economic Indicators - U.S. retail sales rose by 0.6% month-over-month in November, marking the largest increase since July, compared to a revised 0.1% drop in October [2][10] - The U.S. current account deficit decreased by 9.2% to $226.4 billion in Q3, against market expectations of a $238 billion gap [10] - U.S. producer prices increased by 0.2% month-over-month in November, consistent with market expectations [10] Commodity Market - Oil prices rose by 1.3% to $61.97, gold increased by 0.5% to $4,622.10, silver surged by 4.8% to $90.560, and copper rose by 0.3% to $6.0345 [5] European and Asian Markets - European shares were mostly higher, with the eurozone's STOXX 600 up 0.19%, Spain's IBEX 35 up 0.43%, London's FTSE 100 up 0.28%, Germany's DAX down 0.40%, and France's CAC 40 up 0.10% [6] - Asian markets closed mixed, with Japan's Nikkei up 1.48%, Hong Kong's Hang Seng Index up 0.56%, China's Shanghai Composite down 0.31%, and India's BSE Sensex down 0.29% [7] Company-Specific Movements - High Roller Technologies, Inc. shares surged by 289% to $13.64 after announcing a partnership with Crypto.com [9] - Clover Health Investments Corp shares rose by 10% to $2.78 following a year-over-year increase in membership growth [9] - Inspire Veterinary Partners Inc shares increased by 78% to $0.041 after filing to increase its authorized common stock [9] - Briacell Therapeutics Corp shares fell by 53% to $5.09 after pricing a public offering at $5.59 per unit [9] - Plus Therapeutics Inc shares dropped by 39% to $0.29 after announcing a public offering priced at $0.38 per unit [9] - Hub Cyber Security Ltd shares decreased by 39% to $0.33 following a reverse stock split announcement [9]

Market Overview - U.S. stocks experienced a decline, with the Nasdaq Composite falling over 350 points, the Dow down 0.55% to 48,922.97, the NASDAQ down 1.58% to 23,335.70, and the S&P 500 down 1.06% to 6,889.76 [1] - Energy shares increased by 2%, while information technology stocks decreased by 1.3% [1] Retail Sales and Economic Indicators - U.S. retail sales rose by 0.6% month-over-month in November, marking the largest increase since July, compared to a revised 0.1% drop in October [2][10] - The U.S. current account deficit decreased by 9.2% to $226.4 billion in Q3, against market expectations of a $238 billion gap [10] - U.S. producer prices increased by 0.2% month-over-month in November, consistent with market expectations [10] Commodity Market - Oil prices rose by 1.3% to $61.97, gold increased by 0.5% to $4,622.10, silver surged by 4.8% to $90.560, and copper rose by 0.3% to $6.0345 [5] European and Asian Markets - European shares were mostly higher, with the eurozone's STOXX 600 up 0.19%, Spain's IBEX 35 up 0.43%, London's FTSE 100 up 0.28%, Germany's DAX down 0.40%, and France's CAC 40 up 0.10% [6] - Asian markets closed mixed, with Japan's Nikkei up 1.48%, Hong Kong's Hang Seng Index up 0.56%, China's Shanghai Composite down 0.31%, and India's BSE Sensex down 0.29% [7] Company-Specific Movements - High Roller Technologies, Inc. shares surged by 289% to $13.64 after announcing a partnership with Crypto.com [9] - Clover Health Investments Corp shares rose by 10% to $2.78 following a year-over-year increase in membership growth [9] - Inspire Veterinary Partners Inc shares increased by 78% to $0.041 after filing to increase its authorized common stock [9] - Briacell Therapeutics Corp shares fell by 53% to $5.09 after pricing a public offering at $5.59 per unit [9] - Plus Therapeutics Inc shares dropped by 39% to $0.29 after announcing a public offering priced at $0.38 per unit [9] - Hub Cyber Security Ltd shares decreased by 39% to $0.33 following a reverse stock split announcement [9]

Market Overview - U.S. stocks traded lower, with the Nasdaq Composite falling more than 100 points on Wednesday, while the Dow decreased by 0.21% to 49,090.31, the NASDAQ declined 0.67% to 23,551.77, and the S&P 500 dropped 0.47% to 6,931.31 [1] - Energy shares gained by 0.9%, while consumer discretionary stocks dipped by 0.9% [1] Company Earnings - Bank of America Corp reported a net income of $7.6 billion for Q4 fiscal 2025, down from $6.80 billion a year ago, with an EPS of 98 cents, beating the analyst consensus estimate of 96 cents [2] - Revenue increased by 7% year-over-year to $28.532 billion, surpassing the analyst consensus estimate of $27.944 billion [2] Commodity Prices - Oil traded up 1% to $61.73, gold increased by 1% to $4,643.70, silver rose by 5.8% to $91.365, and copper gained 0.5% to $6.0450 [5] Global Market Performance - European shares were mostly higher, with the eurozone's STOXX 600 rising 0.1%, Spain's IBEX 35 Index up 0.4%, London's FTSE 100 gaining 0.3%, Germany's DAX falling 0.5%, and France's CAC 40 rising 0.1% [6] - Asian markets closed mixed, with Japan's Nikkei surging 1.48%, Hong Kong's Hang Seng Index gaining 0.56%, while China's Shanghai Composite fell 0.31% and India's BSE Sensex decreased by 0.29% [7] Stock Movements - High Roller Technologies, Inc. shares surged 322% to $14.65 after announcing a partnership with Crypto.com [8] - Lottery.com Inc shares increased by 87% to $0.96, while Inspire Veterinary Partners Inc shares rose by 99% to $0.046 following an increase in authorized common stock [8] - Briacell Therapeutics Corp shares dropped 53% to $5.11 after pricing a $30 million public offering at $5.59 per unit [8] - Plus Therapeutics Inc shares fell 41% to $0.28 after announcing a $15 million public offering at $0.38 per unit [8] - Hub Cyber Security Ltd shares decreased by 40% to $0.32 after announcing a reverse stock split [8]

Market Overview - U.S. stocks traded lower, with the Nasdaq Composite falling more than 100 points on Wednesday. The Dow decreased by 0.21% to 49,090.31, the NASDAQ declined by 0.67% to 23,551.77, and the S&P 500 fell by 0.47% to 6,931.31 [1] Company Earnings - Bank of America Corp reported a net income of $7.6 billion for Q4 fiscal 2025, down from $6.80 billion a year ago. The EPS was 98 cents, beating the analyst consensus estimate of 96 cents. Revenue increased by 7% year-over-year to $28.532 billion, surpassing the analyst consensus estimate of $27.944 billion [2] Commodity Prices - Oil prices increased by 1% to $61.73, gold rose by 1% to $4,643.70, silver surged by 5.8% to $91.365, and copper gained 0.5% to $6.0450 [5] Stock Movements - High Roller Technologies, Inc. shares surged by 322% to $14.65 after announcing a partnership with Crypto.com. Lottery.com Inc shares increased by 87% to $0.96, while Inspire Veterinary Partners Inc shares rose by 99% to $0.046 following an increase in authorized common stock. Conversely, Briacell Therapeutics Corp shares dropped by 53% to $5.11 after pricing a public offering at $5.59 per unit. Plus Therapeutics Inc shares fell by 41% to $0.28 after announcing a public offering at $0.38 per unit. Hub Cyber Security Ltd shares decreased by 40% to $0.32 after a reverse stock split announcement [8]

Group 1 - U.S. stock futures are lower, with Dow futures down approximately 100 points [1] - Glaukos Corp reported preliminary FY25 sales of $507 million, leading to a 12.1% drop in shares to $96.97 in pre-market trading [1] Group 2 - Briacell Therapeutics Corp experienced a significant decline of 53.1% to $5.12 after announcing a $30 million public offering [2] - Trip.com Group Ltd shares fell 9.3% to $68.55 amid an investigation by China's SAMR for potential anti-monopoly violations [2] - Pearson PLC shares decreased by 7.2% to $13.36 following a trading update for 2025 [2] - Olema Pharmaceuticals Inc shares declined 5.5% to $26.37 after a previous drop of 3% [2] - Fresenius Medical Care AG shares fell 4.8% to $21.79 [2] - Ambitions Enterprise Management Co LLC shares dropped 4.3% to $11.81 after a significant increase of 134% the previous day [2] - NovaBay Pharmaceuticals Inc shares decreased by 3.8% to $12.55 following a 3% drop on Tuesday [2] - SmartRent Inc shares fell 2.3% to $1.74 in pre-market trading [2]

Group 1 - BriaCell Therapeutics Corp. announced a public offering of 5.367 million units priced at $5.59 per unit, aiming for gross proceeds of approximately $30 million [1] - Each unit consists of one common share and one warrant, with the warrant exercisable at $6.93 per share and expiring five years from issuance [1] - Following the announcement, the stock price dropped 54.12% to $5.01 [2] Group 2 - The warrants have been approved for listing on the Nasdaq Capital Market under the symbol "BCTXL," expected to begin trading on January 14, 2026 [2] - The offering is anticipated to close on January 15, 2026 [2] - The company plans to use the net proceeds for working capital and general corporate purposes [3] Group 3 - BriaCell recently reported a sustained complete resolution of lung metastasis in a breast cancer patient treated with its Bria-OTS personalized immunotherapy, boosting stock prices to $12.10 [3] - Over 11 months, the treatment response was confirmed without treatment-limiting toxicities, enhancing confidence in the Bria-OTS platform [4] - The stock traded between $3.00 and $98.20 over the past year, closing at $10.92, up 43.12% prior to the offering announcement [4]

Group 1: Company Performance - Gelteq Ltd (NASDAQ:GELS) shares rose sharply by 50.1% to $1.25 in pre-market trading after reporting positive preclinical results for its cannabinoid oral gel delivery platform [1][2] - The proprietary oral gel platform achieved a greater than 22% increase in the bioavailability of cannabidiol compared to an existing FDA-approved oil-based product [1] Group 2: Other Notable Stock Movements - Inspire Veterinary Partners Inc (NASDAQ:IVP) gained 141.3% to $0.056 after filing a Certificate of Amendment to increase its authorized Class A common stock from 100 million to 700 million shares [5] - Oriental Culture Holding Ltd (NASDAQ:OCG) rose 40.8% to $0.016 following the board's approval of a special cash dividend of 5 cents per share [5] - XCF Global Inc (NASDAQ:SAFX) gained 30.2% to $0.22 after announcing expansion financing plans [5] - AiRWA Inc (NASDAQ:YYAI) rose 15.8% to $1.46 after a director purchased 1.109 million shares at an average price of $1.35 per share [5] - Autolus Therapeutics PLC (NASDAQ:AUTL) gained 7.3% to $1.47 after announcing preliminary fourth-quarter and FY25 revenue results [5] Group 3: Declining Stocks - Briacell Therapeutics Corp (NASDAQ:BCTX) fell 53.1% to $5.12 after announcing the pricing of a $30 million public offering [5] - Moolec Science SA (NASDAQ:MLEC) fell 19.8% to $3.94 after a previous jump of 19% [5] - Hub Cyber Security Ltd (NASDAQ:HUBC) fell 19.1% to $0.43 after gaining 56% on the previous day [5] - Trip.com Group Ltd (NASDAQ:TCOM) dipped 9.3% to $68.55 amid an investigation by China's SAMR for potential anti-monopoly violations [5]

Core Viewpoint - BriaCell Therapeutics Corp. has announced a public offering of 5,366,726 units at a price of $5.59 per unit, aiming to raise approximately $30 million before expenses [1][2]. Group 1: Offering Details - Each unit consists of one common share (or a pre-funded warrant) and one warrant, with the warrants approved for listing on the Nasdaq Capital Market under the symbol "BCTXL" [1]. - The warrants are immediately exercisable at an exercise price of $6.93 per share and will expire five years from issuance [1]. - The offering is expected to close on January 15, 2026, subject to customary closing conditions [2]. Group 2: Use of Proceeds - The net proceeds from the offering will be used to fund working capital requirements, general corporate purposes, and to advance the company's business objectives [3]. Group 3: Regulatory Information - A registration statement related to the securities was filed with the SEC on December 23, 2025, and became effective on January 13, 2026 [4]. - The offering is being made only by means of a prospectus, with copies available from ThinkEquity and on the SEC's website [4]. Group 4: Company Overview - BriaCell is a clinical-stage biotechnology company focused on developing novel immunotherapies to transform cancer care [6].

Core Viewpoint - BriaCell Therapeutics Corp. has announced a public offering of 5,366,726 units at a price of $5.59 per unit, aiming to raise approximately $30 million before expenses [1][2]. Group 1: Offering Details - Each unit consists of one common share (or a pre-funded warrant) and one warrant, with the warrants approved for listing on the Nasdaq Capital Market under the symbol "BCTXL" [1]. - The warrants are immediately exercisable at an exercise price of $6.93 per share and will expire five years from issuance [1]. - The offering is expected to close on January 15, 2026, subject to customary closing conditions [2]. Group 2: Use of Proceeds - The net proceeds from the offering will be used for working capital requirements, general corporate purposes, and advancing the company's business objectives [3]. Group 3: Regulatory Information - A registration statement related to the securities was filed with the SEC on December 23, 2025, and became effective on January 13, 2026 [4]. - The offering is being made only by means of a prospectus, with copies available from ThinkEquity [4]. Group 4: Company Overview - BriaCell is a clinical-stage biotechnology company focused on developing novel immunotherapies to transform cancer care [6].